Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 12/3/2025WuXi Biologics Extends Global CRDMO Network to Qatar
  • 12/2/2025Fangzhou and Tencent Launch Full-Stack AI Platform to Transform Chroni...
  • 12/2/20253SBio Seeks HK$3.12B in HK Share Placement to Accelerate Global Drug D...
  • 12/2/2025Proviva Raises Over US$30M to Advance Next-Gen Cancer Immunotherapies
  • 12/2/2025Lynk Pharma Files for Hong Kong IPO to Accelerate JAK-STAT and TYK2 Dr...
  • 12/1/2025PhIIC Report Highlights China's API Industry Rebound as Adjustment Cyc...
  • 12/1/2025SystImmune Nets $250 Million Milestone from BMS After First‑Patient ...
  • 12/1/2025New ADC Shows Broad Antitumor Activity With Strong Bystander Effect
  • 12/1/2025Lion TCR Partners With SIAT to Advance Universal Cell Therapy for Soli...
  • 12/1/2025Innovent's Pecondle Wins China Approval as First Homegrown IL-23p19 An...
  • 11/28/2025Recent Executive Moves
  • 11/28/2025Gan & Lee Launches GRADUAL-3 Phase 3 Trial of Once-Monthly Bofanglutid...
  • 11/28/2025Zhongmou Reports Strong First-in-Human Results for Optogenetic Gene Th...
  • 11/28/2025WakerBio Raises ~CNY 100M to Accelerate Global CGT Safety and Clinical...
  • 11/28/2025China Expands Grassroots Healthcare Access with More Doctors, Mobile S...
  • 11/28/2025Pierre Fabre Expands Investment in China Thru New Sinopharm Partnersh...
  • 11/28/2025BeOne Secures USFDA Priority Review for Sonrotoclax
  • 11/27/2025Olymvax Files for Hong Kong Listing as Vaccine Pipeline Expands
  • 11/27/2025GlobalData: Ivonescimab Poised to Transform China's TNBC Market
  • 11/27/2025Novartis's Rhapsido Approved for Chronic Spontaneous Urticaria in Chin...
  • 11/27/2025Ascentage Pharma Publishes Phase Ib Data for Olverembatinib in GIST
  • 11/27/2025NMPA Approves AstraZeneca's Imfinzi for NSCLC in China
  • 11/27/2025Biontech to Present Phase 2 Data for Bispecific Antibody Pumitamig in ...
  • 11/27/2025CSPC's JMT206 Wins Green Light for First-in-Human Trials in China
  • 11/27/2025Sugemalimab Wins European Approval for Stage III NSCLC
  • 11/25/2025China Accelerates Investment in Nuclear Medicine Amid Global Radiophar...
  • 11/25/2025Kelun Reports Positive Phase 2 Results for Sac-TMT Combined with KEYTR...
  • 11/25/2025CDE Solicits Comments on Draft Guidance for Computerized Systems and E...
  • 11/25/2025Samsung LS Fund Invests in Phrontline to Boost ADC Development
  • 11/25/2025Amicus Diversifies Manufacturing from China to Reduce Geopolitical Ris...
  • Page:28/62 Total number of articles:1857: [First][<<] [26] [27] [28] [29] [30] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group